Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Hannan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Traffic (Copenhagen, Denmark)|October 18, 2002
Traffic jams II: an update of diseases of intracellular transportMeir Aridor, Lisa A Hannan
Traffic (Copenhagen, Denmark)|December 24, 2016
So Long Tom!Lisa A Hannan, Michael S Marks, Trina A Schroer, et al.
Traffic (Copenhagen, Denmark)|January 19, 2017
Fundamental mechanisms deliver the Nobel Prize to OhsumiSharon A Tooze, Lisa A Hannan, Michael S Marks, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRohit Loomba, Erin Morgan, Lynnetta Watts, et al.
Journal of the Peripheral Nervous System : JPNS|November 8, 2022
Liver-directed drugs for transthyretin-mediated amyloidosisThomas H Brannagan, John L Berk, Julian D Gillmore, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Traffic (Copenhagen, Denmark)|October 18, 2002
Traffic jams II: an update of diseases of intracellular transportMeir Aridor, Lisa A Hannan
Traffic (Copenhagen, Denmark)|December 24, 2016
So Long Tom!Lisa A Hannan, Michael S Marks, Trina A Schroer, et al.
Traffic (Copenhagen, Denmark)|January 19, 2017
Fundamental mechanisms deliver the Nobel Prize to OhsumiSharon A Tooze, Lisa A Hannan, Michael S Marks, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRohit Loomba, Erin Morgan, Lynnetta Watts, et al.
Journal of the Peripheral Nervous System : JPNS|November 8, 2022
Liver-directed drugs for transthyretin-mediated amyloidosisThomas H Brannagan, John L Berk, Julian D Gillmore, et al.
Pageof 1